LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 25.79 | 27.76 | 2305 | 1605 | 1.4360 | 1.1275 | MN20160318_Q01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 27.49 | 27.76 | 1632 | 1723 | 0.9471 | 0.9818 | MN20160318_Q01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 27.49 | 27.76 | 1683 | 1723 | 0.9767 | 0.9921 | MN20160318_Q01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 27.49 | 27.76 | 2399 | 1723 | 1.3922 | 1.1143 | MN20160318_Q01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 27.49 | 27.76 | 2453 | 1723 | 1.4236 | 1.1222 | MN20160318_Q01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 29.19 | 27.76 | 1720 | 1863 | 0.9232 | 0.9738 | MN20160318_Q01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 29.19 | 27.76 | 1773 | 1863 | 0.9516 | 0.9837 | MN20160318_Q01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 29.19 | 27.76 | 2575 | 1863 | 1.3821 | 1.1095 | MN20160318_Q01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 29.19 | 27.76 | 2645 | 1863 | 1.4196 | 1.1189 | MN20160318_Q01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 30.90 | 27.76 | 1874 | 2032 | 0.9221 | 0.9740 | MN20160318_Q01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 30.90 | 27.76 | 1929 | 2032 | 0.9491 | 0.9832 | MN20160318_Q01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 30.90 | 27.76 | 2811 | 2032 | 1.3831 | 1.1075 | MN20160318_Q01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 30.90 | 27.76 | 2855 | 2032 | 1.4048 | 1.1128 | MN20160318_Q01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 32.60 | 27.76 | 2069 | 2235 | 0.9254 | 0.9757 | MN20160318_Q01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 32.60 | 27.76 | 2110 | 2235 | 0.9437 | 0.9818 | MN20160318_Q01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 32.60 | 27.76 | 3052 | 2235 | 1.3650 | 1.1007 | MN20160318_Q01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 32.60 | 27.76 | 3104 | 2235 | 1.3883 | 1.1064 | MN20160318_Q01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 34.30 | 27.76 | 2234 | 2449 | 0.9119 | 0.9717 | MN20160318_Q01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 34.30 | 27.76 | 2269 | 2449 | 0.9262 | 0.9764 | MN20160318_Q01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 34.30 | 27.76 | 3311 | 2449 | 1.3515 | 1.0954 | MN20160318_Q01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 34.30 | 27.76 | 3354 | 2449 | 1.3691 | 1.0996 | MN20160318_Q01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 36.01 | 27.76 | 2415 | 2662 | 0.9069 | 0.9705 | MN20160318_Q01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 36.01 | 27.76 | 2457 | 2662 | 0.9227 | 0.9757 | MN20160318_Q01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 36.01 | 27.76 | 3552 | 2662 | 1.3339 | 1.0895 | MN20160318_Q01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 36.01 | 27.76 | 3591 | 2662 | 1.3485 | 1.0929 | MN20160318_Q01 | J07 |